SavedAdd your journal

Journals / Archives of Rheumatology / 2021 / Cilt: 36 - Sayı: 4

Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients

Sherif M Gamal
Sally S. Mohamed
Marwa Tantawy
Ibrahem Siam
Ahmed Soliman
Marwa H. Niazy
Pages
595–602
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patients with vasculitis had a longer disease duration (p=0.01), were more likely to have juvenile onset (p=0.002), livedo reticularis (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to examine the frequency and clinical association of lupus-related vasculitis in patients with systemic lupus erythematosus (SLE).
📊
Key Findings & Data:Patients and methods: We retrospectively analyzed medical records of a total of 565 SLE patients (42 males, 523 females; mean age: 32.7±9.5 years; range, 13 to 63 years) between January 2017 and February 2020.
💡
Conclusion & Impact:The patients with vasculitis had a longer disease duration (p=0.01), were more likely to have juvenile onset (p=0.002), livedo reticularis (p
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to examine the frequency and clinical association of lupus-related vasculitis in patients with systemic lupus erythematosus (SLE). Patients and methods: We retrospectively analyzed medical records of a total of 565 SLE patients (42 males, 523 females; mean age: 32.7±9.5 years; range, 13 to 63 years) between January 2017 and February 2020. Demographic, clinical data, and laboratory data and treatment modalities applied were recorded. Lupus-related vasculitis and its different types were documented, and the patients with vasculitis were compared with those without vasculitis. Results: The mean disease duration was 8.9±6.3 years. Vasculitis associated with lupus was found in 191 (33.45%) patients. Cutaneous vasculitis was found in 59.2%, visceral vasculitis in 34.0%, and both in 6.8% of total vasculitis patients. The patients with vasculitis had a longer disease duration (p=0.01), were more likely to have juvenile onset (p=0.002), livedo reticularis (p

🔖

Cite This Article

Gamal, S. M., Mohamed, S. S., Tantawy, M., Siam, I., Soliman, A., Niazy, M. H. (2022). Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients. Archives of Rheumatology, Cilt: 36 - Sayı: 4, 595–602. https://ajindex.com/articles/448022

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Fukuda MV, Lo SC, de Almeida CS, Shinjo SK. AntiRo antibody and cutaneous vasculitis in systemic lupus erythematosus. Clin Rheumatol 2009;28:301-4
  2. Albirdisi MR, Al-Homood IA. Characteristics of lupus nephritis in Saudi lupus patients: A retrospective observational study. Lupus 2020;29:1638-43
  3. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-23
  4. Barile-Fabris L, Hernández-Cabrera MF, BarraganGarfias JA. Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep 2014;16:440
  5. Ramos-Casals M, Nardi N, Lagrutta M, BritoZerón P, Bové A, Delgado G, et al. Vasculitis in systemic lupus erythematosus: Prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 2006;85:95-104
  6. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11
  7. Gheita TA, Abaza NM, Sayed S, El-Azkalany GS, Fishawy HS, Eissa AH. Cutaneous vasculitis in systemic lupus erythematosus patients: Potential key players and implications. Lupus 2018;27:738-43
  8. Calamia KT, Balabanova M. Vasculitis in systemic lupus erythematosis. Clin Dermatol 2004;22:148-56
  9. Saleh A, Stone JH. Classification and diagnostic criteria in systemic vasculitis. Best Pract Res Clin Rheumatol 2005;19:209-21
  10. Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, et al. Baseline predictors of systemic lupus erythematosus flares: Data from the combined placebo groups in the phase III belimumab trials. Arthritis Rheum 2013;65:2143-53
  11. Smith EMD, Lythgoe H, Hedrich CM. Vasculitis in juvenile-onset systemic lupus erythematosus. Front Pediatr 2019;7:149
  12. Pyrpasopoulou A, Chatzimichailidou S, Aslanidis S. Vascular disease in systemic lupus erythematosus. Autoimmune Dis 2012;2012:876456
  13. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86
  14. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40
  15. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/Am